NewsBenzingaDr. Reddy's Laboratories: Q2-Gewinn je Aktie 0,12 $ verfehlt Schätzung von 0,16 $, Umsatz 905,000 Mio. $ verfehlt Schätzung von 980,650 Mio. $ Dr. Reddy's Laboratories: Q2-Gewinn je Aktie 0,12 $ verfehlt Schätzung von 0,16 $, Umsatz 905,000 Mio. $ verfehlt Schätzung von 980,650 Mio. $ Benzinga 2026.10.23 12:27 (GMT+0) Open on Benzinga Other news QUICK SPARK: Equifax Goes From Its Worst Month on Record to Its Best $100 Invested In Take-Two Interactive 10 Years Ago Would Be Worth This Much Today Wells Fargo Maintains Overweight on Dover, Raises Price Target to $233 Universal Insurance Hldgs Q3 2026 Earnings Call Transcript 'India's Scotch probe of Diageo, Pernod undermining India-UK pact benefits, trade group says' - Reuters Wells Fargo Maintains Overweight on Ryder System, Raises Price Target to $305
'India's Scotch probe of Diageo, Pernod undermining India-UK pact benefits, trade group says' - Reuters
